Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Bonate

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|March 10, 2001
A brief introduction to Monte Carlo simulationP L Bonate
Clinical Pharmacokinetics|February 1, 1990
Pathophysiology and pharmacokinetics following burn injuryP L Bonate
Clinical Pharmacology and Therapeutics|September 20, 2014
What happened to the modeling and simulation revolution?P L Bonate
Clinical Neuropharmacology|February 1, 1991
Serotonin receptor subtypes: functional, physiological, and clinical correlatesP L Bonate
Journal of Clinical Pharmacology|May 12, 2000
Rank power of metrics used to assess QTc interval prolongation by clinical trial simulationP L Bonate
Journal of Clinical Pharmacology|August 1, 1991
Gender-related differences in xenobiotic metabolismP L Bonate
Journal of Neuroscience Methods|January 1, 1995
Animal models for studying transport across the blood-brain barrierP L Bonate
Pharmaceutical Research|May 9, 2000
Clinical trial simulation in drug developmentP L Bonate
Pharmaceutical Research|June 1, 1999
The effect of collinearity on parameter estimates in nonlinear mixed effect modelsP L Bonate
Pharmaceutical Research|May 1, 1998
Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental designP L Bonate
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|March 10, 2001
A brief introduction to Monte Carlo simulationP L Bonate
Clinical Pharmacokinetics|February 1, 1990
Pathophysiology and pharmacokinetics following burn injuryP L Bonate
Clinical Pharmacology and Therapeutics|September 20, 2014
What happened to the modeling and simulation revolution?P L Bonate
Clinical Neuropharmacology|February 1, 1991
Serotonin receptor subtypes: functional, physiological, and clinical correlatesP L Bonate
Journal of Clinical Pharmacology|May 12, 2000
Rank power of metrics used to assess QTc interval prolongation by clinical trial simulationP L Bonate
Journal of Clinical Pharmacology|August 1, 1991
Gender-related differences in xenobiotic metabolismP L Bonate
Journal of Neuroscience Methods|January 1, 1995
Animal models for studying transport across the blood-brain barrierP L Bonate
Pharmaceutical Research|May 9, 2000
Clinical trial simulation in drug developmentP L Bonate
Pharmaceutical Research|June 1, 1999
The effect of collinearity on parameter estimates in nonlinear mixed effect modelsP L Bonate
Pharmaceutical Research|May 1, 1998
Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental designP L Bonate
Pageof 3